Blood Culture Contamination and the Vancomycin Decision
A 340-bed community hospital tracks blood culture contamination monthly. Last quarter the rate was 3.4% against an internal benchmark of ≤3.0%. Chart review shows most contaminant events come from the emergency department (ED), where the night shift draws most cultures. The ED uses a two-bottle set per draw; skin antisepsis is chlorhexidine-alcohol with a 30-second dry time; phlebotomists report frequent draws through existing peripheral IVs when a fresh venipuncture is difficult. A 68-year-old man with fever (38.6 °C), chills, and a new leukocytosis (15.2 × 10^9/L) is admitted from the ED. One of two culture sets grows coagulase-negative staphylococci in a single anaerobic bottle at 41 hours; the other set is negative at 5 days. He is started on vancomycin. The infectious disease physician asks the laboratory to help interpret the result and address the quarterly contamination rate.
1. Interpret the culture result for this patient and explain the reasoning you would provide to the care team.
Read the worked answer
A single anaerobic bottle growing coagulase-negative staphylococci at 41 hours, with the companion set negative, is most consistent with a contaminant rather than true bacteremia. Reasoning: CoNS is the most common blood culture contaminant; growth in only one of multiple bottles, delayed time-to-positivity, and isolation from a single anaerobic bottle all favor contamination. However, the laboratory cannot declare contamination definitively. The interpretation should be communicated as "probable contaminant; clinical correlation required," and the team should consider whether the patient has a line, prosthetic material, or other risk factors that would warrant a repeat set before stopping therapy. The laboratory should not silently downgrade the result. A repeat culture drawn before antibiotics would strengthen the case; if the patient is already on vancomycin, a repeat set may be negative regardless, so clinical judgment (source, severity, alternate diagnoses) must drive the decision.
2. Identify the process-level contributors to the contamination rate and propose a prioritized corrective action plan.
Read the worked answer
Contributors visible in the setup: (1) draws through existing peripheral IVs, which is a recognized contamination risk and should be avoided when a fresh venipuncture is feasible; (2) night-shift ED workflow, where staffing and time pressure may shorten antisepsis technique; (3) two-bottle sets, which are standard but mean a single contaminated bottle can trigger a positive; (4) possible inadequate dry time if the 30-second chlorhexidine-alcohol dry time is not actually observed. Prioritized plan: retrain ED staff on avoiding IV-line draws and on full 30-second dry time with direct observation; audit technique with a checklist for 4–6 weeks; provide dedicated phlebotomy support at night; track contamination by collector and shift rather than only by unit; consider a diversion/sterile-collection device if the rate does not fall. Re-measure monthly and set a target of ≤3.0%, with a stretch goal of ≤2.0%. The plan should be paired with feedback to individual collectors, not punitive action alone.
3. The ED asks whether to add a third bottle per set to improve sensitivity. How do you respond?
Read the worked answer
Adding a third bottle per set is not the right lever here. The problem is contamination, not sensitivity, and more bottles increase the chance that a contaminant in one bottle triggers a positive result and drives unnecessary vancomycin. Standard practice is two to three sets per septic episode, with volume per bottle being the key sensitivity driver; the priority should be adequate blood volume per bottle (typically 8–10 mL for adult aerobic bottles) and drawing sets before antibiotics. The response should redirect the ED to volume, technique, and timing rather than bottle count, and should note that adding bottles without fixing technique would likely raise the contamination rate and cost.